I-Curantil ibhekisela kumayeza afana ne-antiplatelet (i-antithrombotic) kunye ne-angioprotective (isistim-strengthening-action). Ukongeza, isilwanyana siphucula umzimba .
Isenzo samachiza kunye nendlela yokukhutshwa kwezilwanyana iKurantil
Icandelo eliphambili lequmrhu le-Kurantil - dipyridamole. Into esebenzayo ineempembelelo ezilandelayo zonyango kumzimba:
- ikhulisa i-lumen yeenqanawa ze-coronary;
- ukwandisa isantya sokuhamba kwegazi;
- ivuselela ukubonelelwa kwe-myocardium nge-oxygen;
- ikhuthaza ukuhlanganiswa kwe-interferon;
- inqanda ukuhlanganiswa kweeplatelet egazini.
Ukulungiselela amayeza eKurantil kufumaneka ngendlela:
- amaphilisi ane-25, 50, 75 okanye i-100 mg ye-dipyridamole;
- iindawo ezinama-25 ne-75 mg yesithako esisebenzayo;
- Isisombululo se-0.5% kwi-ampoules.
Iinkcazo kunye nokuchasene nokusetyenziswa kweziyobisi eCraantil
Iimpawu zokusetyenziswa kweziyobisi zonyango iKarantil ngokwemiyalelo yile:
- ukuphulwa kwe-cerebral circulation ngokohlobo lwe-ischemia;
- encephalopathy;
- xi nzelelo;
- ku phelisa i-endarteritis ;
- i-pre-infarction kunye ne-post-infarction ithi;
- i-atherosclerosis yeenqwelo zentliziyo;
- ukuthintela i-thrombosis kunye ne-thromboembolism, kubandakanywa emva kwee-valve heart valves;
- naluphi na ukuphulwa kwegazi lokucwangcisa i-microcirculation;
- ukwandisa umkhuhlane kwizifo zesifo sengculazi kunye ne-ARVI.
Iingcali zikwaqwalasela ukungenakulungeleka kwendawo yokukhulelwa ngexesha lokukhulelwa njengesalathiso sokusetyenziswa kweziyobisi eCraantil. Ukuba isongelo esivela kwimeko esingekho mngcipheko wokuthatha iyeza, unikwe umama ozayo.
Ukungqinelana nokusetyenziswa kweziyobisi i-Kurantil zizifo ezinzima ezichaphazelekayo nokuphulwa kwegazi, ukungaqiniseki kunye neemeko ezihlawulelwayo. Isilwayo asimiswanga kwezi zifo zilandelayo:
- i-myocardial okanye i-brain infarction;
- i-angina;
- hypotension, syncope;
- ephawulwe ngokungahambi kakuhle;
- Ukungaphumeleli kwentliziyo kwinqanaba lokunciphisa;
- i-dystonia yemifuno;
- ukuphazamiseka kwenkqubo ye-bronchopulmonary;
- ukutyekela ukuphuma kwamanzi, kubandakanyeka phambi kweso sesilonda;
- i-arrhythmias yenyama;
- i-hypersensitive to components.
Kuyinto engathandekiyo ukusebenzisa uCurantil kunyango lwabantwana abangaphantsi kweminyaka eyi-12 ubudala.
Indlela yokusetyenziswa kweziyobisi iCrantil
Ngomlomo, kucetyiswa ukuthatha iChurantil ngaphambi kokutya okanye iiyure ezimbini emva kokutya. Iiblulethi (i-dragees) kufuneka ihlanjwe ngexabiso elaneleyo lamanzi okanye ubisi (oku kunciphisa iziganeko zedhudo). Oogqirha bacebisa ukuba bangasebenzisi itiye kunye nekhofi kwonyango, ekubeni ezi ziphuzo zonakalisa isenzo se-dipyridamole. Kuyafaneleka ukuba uqaphele ukuba i-Curantil iphakamisa umphumo weziyobisi ezingekho emlonyeni kunye neziyobisi ezihlambulula igazi.
Umthamo weziyobisi kuxhomekeke kwinqanaba lokuphuhliswa kwesifo kunye neempawu zomntu ngamnye. I-Courantil kwi-dosage ye-75 mg inomthamo osebenzayo. Izibonakaliso zokusetyenziswa kweziyobisi iCrantil 75, njengomthetho, ziyaphumelela intliziyo kunye nokuphazamiseka kwemisipha ye-cerebral. Ngezifo zolu hlobo, ubude beyeza mayeza ngama-3-6 maxesha ngosuku. Njenge-agent antigregregant, i-Curantil 75 imiselwe kumlinganiselo wee-tablet 3-9 ngosuku.
Ukukhusela izifo zentsholongwane, i-Kurantil idla ngokusetyenziswa kwimiyinge ye-25 Le nyeza icetyiswa ngexesha leengcinezelo ukusela kabini ngosuku kwiipilisi ezi-2 ngenye yamkelwa.